...
首页> 外文期刊>Forensic toxicology >Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013
【24h】

Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013

机译:在韩国滥用的合成大麻素:2009年至2013年6月,国家司法鉴定所对毒品进行了鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

The rapid increase in the number of new psy-choactive substances and their abuse is the most recent drug abuse issue worldwide. Although abuse of synthetic cannabinoids is highly restricted in South Korea, the rapid increase in the number of new substances is forcing the legal regulation authority to continuously improve the drug regulation act. As a result of drug screening by the National Forensic Service from 2009 to June 2013, 26 species of synthetic cannabinoids were identified in materials seized mainly by the Police Agency and the Prosecutor's Office in South Korea. One of the most remarkable trends in synthetic cannabinoids is the increase in halogenated derivatives and new substances, including UR-144 and A-836,339 originally developed as analgesics by Abbott Laboratories. The N-pentyl fluorinated analog of UR-144 (XLR-11) has become the most frequently found synthetic cannabinoid in 2013 since its first appearance in 2012, whereas abuse of A-836,339 analogs has been little reported despite their abuse potential. Until early 2011, nicotine was the most frequently found active coingredient with synthetic cannabinoids. However, various psychoac-tive substances such as DELTA~9-tetrahydrocannabinol, alpha-pyrro-lidinobutiophenone, alpha-pyrrolidinovalerothiophenone, and N, N-diallyl-5-methoxytryptamine have often been found as coingredients in herbal highs since late 2011. These coin-gredients should also be systematically regulated, because they can cause unexpected side effects. It is suggested thatauthorities in different countries share information about synthetic cannabinoids and their coingredients.
机译:新的灵敏活性物质及其滥用的数量迅速增加是世界范围内最近的药物滥用问题。尽管在韩国对合成大麻素的滥用进行了严格限制,但新物质数量的迅速增加正迫使法律监管机构不断改进药物监管法案。 2009年至2013年6月,国家法医局对毒品进行了筛选,结果在主要由韩国警察局和检察官办公室缉获的材料中鉴定出26种合成大麻素。合成大麻素最显着的趋势之一是卤代衍生物和新物质的增加,包括UR-144和A-836,339,最初是由Abbott Laboratories生产的止痛药。自2012年首次出现以来,UR-144(XLR-11)的N-戊基氟化类似物已成为2013年最常发现的合成大麻素,而几乎没有关于滥用A-836,339类似物的报道。直到2011年初,尼古丁是合成大麻素中最常见的活性成分。但是,自2011年下半年以来,经常在草药高中发现各种精神活性物质,例如DELTA〜9-四氢大麻酚,α-吡咯-利蒂诺丁苯酮,α-吡咯烷基戊噻吩酮和N,N-二烯丙基-5-甲氧基色胺。 -成分也应受到系统的监管,因为它们可能会导致意想不到的副作用。建议不同国家的当局共享有关合成大麻素及其成分的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号